Skip to main content
Erschienen in: Journal of General Internal Medicine 12/2007

01.12.2007 | Original Article

Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled Trial

verfasst von: Simona Bo, MD, Giovannino Ciccone, MD, PhD, Carla Baldi, MD, Lorenzo Benini, MD, Ferruccio Dusio, MD, Giuseppe Forastiere, MD, Claudio Lucia, MD, Claudio Nuti, MD, Marilena Durazzo, MD, Maurizio Cassader, MD, Luigi Gentile, MD, Gianfranco Pagano, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Intensive lifestyle intervention significantly reduces the progression to diabetes in high-risk individuals.

OBJECTIVE

It is not known whether a program of moderate intervention might effectively reduce metabolic abnormalities in the general population.

DESIGN

Two-arm randomized controlled 1-year trial.

PATIENTS

Three hundred and thirty-five patients participated from a dysmetabolic population-based cohort of 375 adults aged 45–64 years in northwestern Italy.

MEASUREMENTS

We compared the effectiveness of a general recommendation-based program of lifestyle intervention carried out by trained professionals versus standard unstructured information given by family physicians at reducing the prevalence of multiple metabolic and inflammatory abnormalities.

RESULTS

At baseline, clinical/anthropometric/laboratory and lifestyle characteristics of the intervention (n = 169) and control (n = 166) groups were not significantly different. The former significantly reduced total/saturated fat intake and increased polyunsaturated fat/fiber intake and exercise level compared to the controls. Weight, waist circumference, high-sensitivity C-reactive protein, and most of the metabolic syndrome components decreased in the intervention group and increased in the controls after 12 months. Lifestyle intervention significantly reduced metabolic syndrome (odds ratio [OR] = 0.28; 95% CI 0.18–0.44), with a 31% (21–41) absolute risk reduction, corresponding to 3.2 (2–5) patients needing to be treated to prevent 1 case after 12 months. The intervention significantly reduced the prevalence of central obesity (OR = 0.33; 0.20–0.56), and hypertriglyceridemia (OR = 0.48; 0.31–0.75) and the incidence of diabetes (OR = 0.23; 0.06–0.85).

CONCLUSION

A lifestyle intervention based on general recommendations was effective in reducing multiple metabolic/inflammatory abnormalities. The usual care by family physicians was ineffective at modifying progressive metabolic deterioration in high-risk individuals.
Literatur
1.
Zurück zum Zitat Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.PubMedCrossRef Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.PubMedCrossRef
2.
Zurück zum Zitat Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef
3.
Zurück zum Zitat The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRef The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRef
4.
Zurück zum Zitat Herman WH, Herger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification on metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-32.PubMed Herman WH, Herger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification on metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-32.PubMed
5.
Zurück zum Zitat Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251–64.PubMed Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251–64.PubMed
6.
Zurück zum Zitat Isooma B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.CrossRef Isooma B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.CrossRef
7.
Zurück zum Zitat Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care. 2003;26:3153–9.PubMedCrossRef Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes. Diabetes Care. 2003;26:3153–9.PubMedCrossRef
8.
Zurück zum Zitat National Institute of Health. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef National Institute of Health. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
9.
Zurück zum Zitat Ford ES. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care. 2005;28:1769–78.PubMedCrossRef Ford ES. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care. 2005;28:1769–78.PubMedCrossRef
10.
Zurück zum Zitat Kahn R, Buse J, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005;48:1684–99.PubMedCrossRef Kahn R, Buse J, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005;48:1684–99.PubMedCrossRef
11.
Zurück zum Zitat Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003;107:391–7.PubMedCrossRef Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003;107:391–7.PubMedCrossRef
12.
Zurück zum Zitat Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program Randomized Trial. Ann Intern Med. 2005;142:611–9.PubMed Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program Randomized Trial. Ann Intern Med. 2005;142:611–9.PubMed
13.
Zurück zum Zitat Kukkonen-Harjula KT, Borg PT, Nenonen AM, Fogelholm MG. Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men. Prev Med. 2005;41:784–90.PubMedCrossRef Kukkonen-Harjula KT, Borg PT, Nenonen AM, Fogelholm MG. Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men. Prev Med. 2005;41:784–90.PubMedCrossRef
14.
Zurück zum Zitat Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292:1440–6.PubMedCrossRef Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA. 2004;292:1440–6.PubMedCrossRef
15.
Zurück zum Zitat Azadbakht L, Mirmiran P, Esmaillzader A, et al. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28:2823–31.PubMedCrossRef Azadbakht L, Mirmiran P, Esmaillzader A, et al. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28:2823–31.PubMedCrossRef
16.
Zurück zum Zitat Poppitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75:11–20.PubMed Poppitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75:11–20.PubMed
17.
Zurück zum Zitat Sacerdote C, Fiorini L, Rosato R, et al. Randomized controlled trial: effect of nutritional counseling in general practice. Int J Epidemiol. 2006;35:409–15.PubMedCrossRef Sacerdote C, Fiorini L, Rosato R, et al. Randomized controlled trial: effect of nutritional counseling in general practice. Int J Epidemiol. 2006;35:409–15.PubMedCrossRef
18.
Zurück zum Zitat Bo S, Gentile L, Ciccone G, et al. The metabolic syndrome and high C-reactive protein: prevalence and difference by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21:515–24.PubMedCrossRef Bo S, Gentile L, Ciccone G, et al. The metabolic syndrome and high C-reactive protein: prevalence and difference by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21:515–24.PubMedCrossRef
19.
Zurück zum Zitat The practical guide. Identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication number 00-4084; October 2000 The practical guide. Identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication number 00-4084; October 2000
20.
Zurück zum Zitat Bo S, Menato G, Lezo A, et al. Dietary fat and gestational hyperglycemia. Diabetologia. 2001;44:972-8.PubMedCrossRef Bo S, Menato G, Lezo A, et al. Dietary fat and gestational hyperglycemia. Diabetologia. 2001;44:972-8.PubMedCrossRef
21.
Zurück zum Zitat Taylor HL, Jacobs DR Jr, Schucker B, et al. Questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31:741–55.PubMedCrossRef Taylor HL, Jacobs DR Jr, Schucker B, et al. Questionnaire for the assessment of leisure time physical activities. J Chronic Dis. 1978;31:741–55.PubMedCrossRef
22.
Zurück zum Zitat The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:S5–20.CrossRef The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:S5–20.CrossRef
23.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.PubMedCrossRef
24.
Zurück zum Zitat Ross R, Dagnone D, Jones PJH, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med. 2000;133:92–103.PubMed Ross R, Dagnone D, Jones PJH, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med. 2000;133:92–103.PubMed
25.
Zurück zum Zitat Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study. Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230–6.PubMedCrossRef Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study. Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230–6.PubMedCrossRef
26.
Zurück zum Zitat Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fiber are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia. 1997;40:430–8.PubMedCrossRef Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fiber are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia. 1997;40:430–8.PubMedCrossRef
27.
Zurück zum Zitat McKeon NM, Meigs JB, Liu S, et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004;27:538–46.CrossRef McKeon NM, Meigs JB, Liu S, et al. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care. 2004;27:538–46.CrossRef
28.
Zurück zum Zitat Freire RD, Cardoso MA, Gimeno SGA, Ferreira SRG. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005;28:1779–85.PubMedCrossRef Freire RD, Cardoso MA, Gimeno SGA, Ferreira SRG. Dietary fat is associated with metabolic syndrome in Japanese Brazilians. Diabetes Care. 2005;28:1779–85.PubMedCrossRef
29.
Zurück zum Zitat Klein-Platat C, Drai J, Oujaa M, et al. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr. 2005;82:1178–84.PubMed Klein-Platat C, Drai J, Oujaa M, et al. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr. 2005;82:1178–84.PubMed
30.
Zurück zum Zitat Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol. 2006;26:995–1001.PubMedCrossRef Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol. 2006;26:995–1001.PubMedCrossRef
31.
Zurück zum Zitat Laaksonen DE, Lakka HM, Salonen JT, et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002;25:1612–8.PubMedCrossRef Laaksonen DE, Lakka HM, Salonen JT, et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care. 2002;25:1612–8.PubMedCrossRef
32.
Zurück zum Zitat Aronson D, Sella R, Sheikh-Ahmad M, et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004;44:2003–7.PubMedCrossRef Aronson D, Sella R, Sheikh-Ahmad M, et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004;44:2003–7.PubMedCrossRef
33.
Zurück zum Zitat Dallongeville J, Cottel D, Ferrières J, et al. Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care. 2005;28:409–15.PubMedCrossRef Dallongeville J, Cottel D, Ferrières J, et al. Household income is associated with the risk of metabolic syndrome in a sex-specific manner. Diabetes Care. 2005;28:409–15.PubMedCrossRef
34.
Zurück zum Zitat The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28:888–94.CrossRef The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28:888–94.CrossRef
35.
Zurück zum Zitat Hillier TA, Fagot-Campagna A, Eschwège E, et al. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR Cohort. Int J Epidemiol. 2006;35:190–6.PubMedCrossRef Hillier TA, Fagot-Campagna A, Eschwège E, et al. Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the DESIR Cohort. Int J Epidemiol. 2006;35:190–6.PubMedCrossRef
36.
Zurück zum Zitat Thompson RL, Summerbell CD, Hooper L, et al. Relative efficacy of differential methods of dietary advice: a systematic review. Am J Clin Nutr. 2003;77:1052S–1057S.PubMed Thompson RL, Summerbell CD, Hooper L, et al. Relative efficacy of differential methods of dietary advice: a systematic review. Am J Clin Nutr. 2003;77:1052S–1057S.PubMed
37.
Zurück zum Zitat Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366:1954–9.PubMedCrossRef Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366:1954–9.PubMedCrossRef
Metadaten
Titel
Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled Trial
verfasst von
Simona Bo, MD
Giovannino Ciccone, MD, PhD
Carla Baldi, MD
Lorenzo Benini, MD
Ferruccio Dusio, MD
Giuseppe Forastiere, MD
Claudio Lucia, MD
Claudio Nuti, MD
Marilena Durazzo, MD
Maurizio Cassader, MD
Luigi Gentile, MD
Gianfranco Pagano, MD
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 12/2007
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0399-6

Weitere Artikel der Ausgabe 12/2007

Journal of General Internal Medicine 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.